Skip to main content
OpenTrials

Clinical trial condition

Fallopian Tube Diseases

Explore clinical trials studying Fallopian Tube Diseases. Study availability and eligibility vary by location and protocol.

598 public trials 89 recruiting studies
Refine in advanced search Browse all conditions

Fallopian Tube Diseases trial results

Completed

An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

NCT01932125

Conditions
Abdominal Neoplasms, Adnexal Diseases, Digestive System Diseases, +19 more
Locations
  • Manipal Hospital Bangalore, Karnataka, India
  • HealthCare Global Enterprises Limited Banglore, Karnataka, India
  • Marthwada Regional Cancer Center & Research Institute Aurangabad, Maharashtra, India
  • MOC Cancer Care & Research Centre Mumbai, Maharashtra, India
View all 13 locations
View Trial Details
Completed

A Study of CDX-585 in Patients With Advanced Malignancies

NCT05788484

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +64 more
Locations
  • George Washington University Cancer Center Washington D.C., District of Columbia, United States
  • AdventHealth Celebration Celebration, Florida, United States
  • Perlmutter Cancer Center at NYU Langone Health New York, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer

NCT03783949

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Medical University of Innsbruck Innsbruck, Austria
  • UZLeuven Leuven, Vlaams-Brabant, Belgium
  • Centre de lutte contre le cancer Francois Baclesse Caen, France
  • Centre anticancereux Leon Berard Lyon, France
View all 13 locations
View Trial Details
Completed

Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02713386

Conditions
Adnexal Diseases, FIGO Stage III Ovarian Cancer 2014, FIGO Stage IIIA Ovarian Cancer 2014, +35 more
Locations
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • Sutter Auburn Faith Hospital Auburn, California, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • Sutter Roseville Medical Center Roseville, California, United States
View all 110 locations
View Trial Details
Completed

Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03206047

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +20 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 17 locations
View Trial Details

Related conditions